Sleeve gastrectomy carries a risk of exacerbating pre-existing gastroesophageal reflux disease or developing de novo disease.
This review highlights the incidence, pathophysiology, and management of GERD following sleeve gastrectomy, a common complication of this bariatric procedure.
Obesity is associated with serious comorbidities and economic implications. Bariatric surgery, most commonly Roux-en-Y gastric bypass and sleeve gastrectomy, are effective options for weight loss and the improvement of obesity-related comorbidities. With the growing obesity epidemic, there has been a concomitant rise in bariatric surgeries, particularly in sleeve gastrectomy, which has been the most widely performed bariatric surgery since 2013. Gastroesophageal reflux disease (GERD) is highly prevalent in obese individuals, can significantly impact quality of life and may lead to serious complications. Obesity and GERD both improve with weight loss. However, as the incidence of sleeve gastrectomy rises, recent data have revealed a risk of exacerbation of pre-existing GERD or the development of de novo GERD following sleeve gastrectomy. We performed a detailed review of GERD post-sleeve gastrectomy, including its overall incidence, pathophysiology and current treatment paradigms.
Masood et al. (Thu,) conducted a review in Gastroesophageal reflux disease (GERD) following sleeve gastrectomy. Sleeve gastrectomy was evaluated on Incidence, pathophysiology and current treatment paradigms of GERD post-sleeve gastrectomy. Sleeve gastrectomy carries a risk of exacerbating pre-existing gastroesophageal reflux disease or developing de novo disease.